Li J - Search Results

1

miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.

Guo S, Xu X, Tang Y, Zhang C, Li J, Ouyang Y, Ju J, Bie P, Wang H. Guo S, et al. Among authors: li j. Cancer Lett. 2014 Mar 1;344(1):40-46. doi: 10.1016/j.canlet.2013.10.009. Epub 2013 Nov 16. Cancer Lett. 2014. PMID: 24252251

2

Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking.

Li J, Zucker S, Pulkoski-Gross A, Kuscu C, Karaayvaz M, Ju J, Yao H, Song E, Cao J. Li J, et al. PLoS One. 2012;7(6):e38403. doi: 10.1371/journal.pone.0038403. Epub 2012 Jun 5. PLoS One. 2012. PMID: 22679501 Free PMC article.

3

VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.

Luo M, Hou L, Li J, Shao S, Huang S, Meng D, Liu L, Feng L, Xia P, Qin T, Zhao X. Luo M, et al. Among authors: li j. Cancer Lett. 2016 Apr 1;373(1):1-11. doi: 10.1016/j.canlet.2016.01.010. Epub 2016 Jan 19. Cancer Lett. 2016. PMID: 26805761 Free article.

4

Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.

Dufour A, Sampson NS, Li J, Kuscu C, Rizzo RC, Deleon JL, Zhi J, Jaber N, Liu E, Zucker S, Cao J. Dufour A, et al. Among authors: li j. Cancer Res. 2011 Jul 15;71(14):4977-88. doi: 10.1158/0008-5472.CAN-10-4552. Epub 2011 Jun 6. Cancer Res. 2011. PMID: 21646471 Free PMC article.

5

Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells.

Hu Q, Gong JP, Li J, Zhong SL, Chen WX, Zhang JY, Ma TF, Ji H, Lv MM, Zhao JH, Tang JH. Hu Q, et al. Among authors: li j. Asian Pac J Cancer Prev. 2014;15(13):5137-42. doi: 10.7314/apjcp.2014.15.13.5137. Asian Pac J Cancer Prev. 2014. PMID: 25040964 Free article.

6

LncRNA LINC01061 sponges miR-612 to regulate the oncogenic role of SEMA4D in cholangiocarcinoma.

Yu A, Zhao L, Kang Q, Chen K, Li J, Fu H, Liu J, Zhang X. Yu A, et al. Among authors: li j. Biochem Biophys Res Commun. 2019 May 28;513(2):465-471. doi: 10.1016/j.bbrc.2019.03.125. Epub 2019 Apr 6. Biochem Biophys Res Commun. 2019. PMID: 30967271

7

Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met.

Chen T, Cai SL, Li J, Qi ZP, Li XQ, Ye LC, Xie XF, Hou YY, Yao LQ, Xu MD, Zhou PH, Xu JM, Zhong YS. Chen T, et al. Among authors: li j, li xq. Sci Rep. 2017 Mar 14;7:44543. doi: 10.1038/srep44543. Sci Rep. 2017. PMID: 28291253 Free PMC article.

8

MiR-139-5p: promising biomarker for cancer.

Zhang HD, Jiang LH, Sun DW, Li J, Tang JH. Zhang HD, et al. Among authors: li j. Tumour Biol. 2015 Mar;36(3):1355-65. doi: 10.1007/s13277-015-3199-3. Epub 2015 Feb 19. Tumour Biol. 2015. PMID: 25691250 Review.

9

MicroRNA-224: as a potential target for miR-based therapy of cancer.

Chen W, Fan XM, Mao L, Zhang JY, Li J, Wu JZ, Tang JH. Chen W, et al. Among authors: li j. Tumour Biol. 2015 Sep;36(9):6645-52. doi: 10.1007/s13277-015-3883-3. Epub 2015 Aug 8. Tumour Biol. 2015. PMID: 26254100 Review.

10

MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.

Zhang HD, Sun DW, Mao L, Zhang J, Jiang LH, Li J, Wu Y, Ji H, Chen W, Wang J, Ma R, Cao HX, Wu JZ, Tang JH. Zhang HD, et al. Among authors: li j. Biochem Biophys Res Commun. 2015 Oct 2;465(4):702-13. doi: 10.1016/j.bbrc.2015.08.053. Epub 2015 Aug 20. Biochem Biophys Res Commun. 2015. PMID: 26299922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195,080 results

Search Page

Filters